Differential responsiveness to immunoablative therapy in refractory rheumatoid arthritis is associated with level and avidity of anti-cyclic citrullinated protein autoantibodies: a case study
-
* Corresponding author: Jacob M van Laar j.m.van-laar@ncl.ac.uk
Arthritis Research & Therapy 2007, 9:R106 doi:10.1186/ar2309
No comments have yet been made on this article.